ETS1 mediates MEK1/2-dependent overexpression of cancerous inhibitor of protein phosphatase 2A (CIP2A) in human cancer cells. by Anchit Khanna, Juha Okkeri, Turker Bilgen, Timo Tiirikka, Mauno Vihinen, Tapio Visakorpi, Jukka Westermarck

Get full text

The PP2A regulator IER5L supports prostate cancer progression by Jana R. Crespo, Natalia Martín-Martín, Saioa Garcia-Longarte, Jon Corres-Mendizabal, Onintza Carlevaris, Ianire Astobiza, Amaia Zabala-Letona, Marc Guiu, Mikel Azkargorta, Monika Gonzalez-Lopez, Nuria Macías-Cámara, Phuong Doan, Félix Elortza, Isabel Mendizabal, Jukka Westermarck, Roger R. Gomis, Amaia Ercilla, Arkaitz Carracedo

Get full text

Correction: The PP2A regulator IER5L supports prostate cancer progression by Jana R. Crespo, Natalia Martín-Martín, Saioa Garcia-Longarte, Jon Corres-Mendizabal, Onintza Carlevaris, Ianire Astobiza, Amaia Zabala-Letona, Marc Guiu, Mikel Azkargorta, Monika Gonzalez-Lopez, Nuria Macías-Cámara, Phuong Doan, Félix Elortza, Isabel Mendizabal, Jukka Westermarck, Roger R. Gomis, Amaia Ercilla, Arkaitz Carracedo

Get full text

LIMA1-alpha staining predicts curative intent surgery response in HPV negative head and neck cancer by Xi Qiao, Johannes Routila, Mari Tienhaara, Heikki Irjala, Priyadharshini Parimelazhagan Santhi, Teemu Huusko, Linda Nissi, Ilkka Paatero, Noora Lehtinen, Juha Rantala, Toni Viljanen, Ilmo Leivo, Petri Koivunen, Anna Jouppila-Mättö, Rami Taulu, Leif Bäck, Tommy Wilkman, Eeva Haapio, Ilpo Kinnunen, Kari Kurppa, Jukka Westermarck, Sami Ventelä

Get full text